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Transplantation of the Kidney 
HETEROTRANSPLANTATION of sub- for subsequent trials. Two patients provided 
human primate kidneys to patients suffering 
from uremia was initially attempted in the late 
19th Century. The first effort at homotrans- 
plantation was made by Voronoy in Russia in 
1936. In the succeeding 16 years there were 
additional sporadic efforts at clinical renal 
homotransplantation. first without immunosup- 
pressive therapy and later with total body 
irradiation of the recipient. The almost uni- 
versal failure of these attempts provided little 
reason to hope that transplantation of the kid- 
ney would ever be a clinically useful method 
of therapy. 
Despite the tragedies and disappointments, 
these pioneer efforts established a foundation 
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in 1958 and 1959 wit11 kidneys from their fra- 
ternal twins in Boston and Paris, respectively, 
are still alive; both received sublethal total 
body irradiation. Using the same therapy, 
Hamburger, Dempster, and Kuss reported non- 
twin cases in which chronic survival was 
achieved. A cousin was the donor for Ham- 
burger's patient, a brother for Dempster's, and 
a non-related cadaver for Kuss's. 
In the meantime, important experience was 
accumulated from study of identical twin cases 
studied in Boston by Merrill and Murray. Since 
an immunologic barrier is not present under 
these circumstances, it was more easily possible 
to define the technical requisites for success, to 
obtain valuable information about the response 
of the recipients to rapid correction of their 
uremic state, and to define both the risks and 
the prognosis of the donors. 
196 MEDICAL TIMES 
In 1962 a sudden change took place in the 
outlook after renal homotransplantation, a 
change which was brought about by the em- 
ployment of certain pharmacologic agents for 
immunosuppression. It seemed at first that 
these agents had a considerably greater margin 
of safety than ionizing irradiation, although 
subsequently Hamburger and his associates 
have achieved almost equivalent results with 
total body irradiation. In the ensuing 4 years, 
a large number of patients have been treated 
with renal homotransplantation, approximately 
1,000 cases in all. Although the techniques 
currently available are still imperfect, the re- 
sults have established beyond doubt that trans- 
plantation of the kidney and other organs can 
be expected to occupy a prominent place in 
the therapeutic armamentarium of the future. 
WHAT HAS BEEN ACCOMPLISHED? 
During the early part of what might be 
termed the modern era of renal transplantation, 
every group was undergoing a learning process. 
Mistakes in both the surgical and medical ther- 
apy were common. In addition, there was at 
this time no practical way of determining prior 
to operation whether or not a biologically suit- 
able donor was being employed. The match- 
ing of donors and recipients was on an entirely 
fortuitous basis without any predictability 
about the magnitude and perseverance of the 
subsequently expected rejection. 
Despite these very severe limitations, sub- 
stantial chronic survival was attained in a num- 
ber of centers. At the University of Colorado 
Medical Center and Denver Veterans Admin- 
istration Hospital a group of 64 patients were 
treated with kidneys from living volunteer 
donors between November of 1962 and March 
of 1964. Thirty-seven of these patients lived 
for as long as one year, 34 lived for at least 
two years, and on June 15, 1966, 33 are still 
surviving after 2% and 3% years (Figure 1). 
All of these patients except one are still living 
on the function of a single kidney; the excep- 
tional patient has been re-transplanted. 
In the original series in which donor- 
recipient pairing was on a random basis, there 
was a highly significant difference in the results 
when blood relatives were used as donors com- 
pared to that achieved with non-related donors. 
Of 46 patients who received kidneys from par- 
ents, siblings, aunts, uncles, or cousins (exclud- 
ing, of course, identical twins), 31 or 67% 
lived for 1 year, 30 for at least 2 years, and 29. 
until the present time. In contrast, only 6 of 
the 18 patients who received non-related kid- 
neys lived for as long as 1 year and only 4 of 
these passed the 2-year mark (Figure 2 ) .  
Experience with this original group of cases 
supports several general conclusions. First, 
more than half of the total group of patients 
achieved extremely worthwhile palliation. The 
vast majority of these chronically surviving pa- 
tients are leading useful lives, and have been 
relatively completely rehabilitated. It has been 
equally evident that certain penalties are neces- 
sary. Disease entities attributable to the im- 
munosuppressive agents have been seen. The 
expense of caring for these patients has been 
great, especially in the early months after 
operation. The need for further improvement 
of technique is most keenly appreciated by 
those who actually have had experience in this 
field. 
CANDIDATES FOR RENAL 
HOMOTRANSPLANTATION 
With the present incomplete state of knowl- 
edge, it is essential that the patient be truly 
terminal with a life expectancy limited to a few 
days or weeks without either renal dialysis or 
transplantation. To qualify for candidacy it is 
desirable that the patient be young, preferably 
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LIVING DONOR SERIES 
FIGURE 1 Life survival curve o f  64 consecutive cases 
treated a t  the University o f  Colorado Medical Center 
with kidneys obtained from living volunteer donors. The 
curve is up  t o  date June 15, 1966. All surviving patients 
are already t o  the r ight of the arrow. Note after 2y3 
years that  more than half of the total group are still alive. 
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FIGURE 2 Breakdown o f  the total results shown in 
Figure I according t o  the source o f  the homograft. Note 
that approximately 2/3 of the patients who received kidneys 
from related donors are still alive, compared t o  0.11~ 
22% o f  those who received non-related kidneys. 
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less than 40 years of age. He should be free 
of other disease. In this age group the most 
important cause of involvement of other organ 
systems is the renal failure itself since diffuse 
vascular disease, myocardial injury, brain in- 
volvement, or pancreatitis are all complications 
of uremia. 
Because immunosuppressive agents will en- 
evitably reduce the immunologic reactivity of 
the recipient, it is mandatory that all foci of 
infection be eliminated in advance of opera- 
tion. Finally, the presence of a normal lower 
urinary tract should be proven. As a research 
undertaking, Kelly and his associates at the 
University of Minnesota are evaluating the 
feasibility of employing ileal conduits as re- 
ceptors for the homograft urine excretion in 
patients with diseased bladders. As worthwhile 
as these investigations are, the additional risk 
under these circumstances would preclude the 
patient for consideration in most transplanta- 
tion clinics at the present time. 
The final decision for or against transplanta- 
tion is inevitably influenced by the presence or 
absence of a suitable donor. During the days 
when preoperative antigen testing was not pos- 
sible, the unavailability of a familial donor in- 
variably created grave questions about the 
advisability of proceeding in view of the very 
poor results then being obtained with non- 
related kidneys. As will be discussed below, 
there is some hope that this situation is chang- 
ing. 
DONOR SELECTION 
To be considered as a living donor a volun- 
teer should be less than 50 years of age, in 
perfect health, and with proven normal renal 
function. A careful history, physical exarnina- 
tion, and electrocardiogram will eliminate a 
surprisingly large number of candidates. Part 
of the evaluation of renal function includes de- 
Direction of Acceptable Mismatched 
Tissue Transfer * 
0 to non 0 Safe 
RH- to RH+ Safe 
RH+ to RH- Relatively safe 
A to non A Dangerous 
B to non B Dangerous 
AB to non AB Dangerous 
* 0 is universal donor 
AB is universal recipient 
TABLE 1 
termination of creatinine, inulin and para- 
aminohippurate (PAH) clearances. If these are 
normal, an intravenous pyleogram and aorto- 
gram are obtained as the final steps. It is our 
general policy not to attempt transplantation of 
a kidney which has a multiple arterial supply. 
Although such an organ can be readily re- 
vascularized, the necessary ischemic interval is 
inevitably increased. 
Knowledge of the blood type of the re- 
cipient and the respective donors is essen- 
tial information in screening a potential donor 
pool. Ideally, the donor and recipient should 
have the same blood type. However, various 
combinations in which this is not the case are 
perfectly acceptable. These are summarized in 
Table 1. It will be noted that the rules for 
transplantation in the absence of blood group 
conformity are essentially the same as those 
which apply to the use of non-matched blood. 
The 0 patient who is a universal donor could 
receive only from another person with 0 blood 
type; conversely, an AB patient is a universal 
recipient but could donate only to another 
patient of AB type. In the absence of presen- 
sitization, the Rh antigen is apparently not an 
important factor. 
It  is necessary to provide protection to the 
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donor from social pressures which may be 
brought to bear upon him. This is particularly 
apt to be a problem within certain families in 
which a priority of expendability has been 
ascribed to certain members. The potential 
donors are examined by psychologists or 
psychiatrists. If evidence of coercion is uncov- 
ered, the patient is pronounced unfit for nledi- 
cal reasons, thereby sparing him from both 
personal guilt feelings and ostracism from his 
parents or siblings. 
It was not formerly possible to attempt 
donor screening except by the very crude nleth- 
ods just alluded to. Consequently, the trans- 
plantation itself served as a biologic test system 
in which those patients who had accidentally 
achieved a good histocompatibility match with 
their donors were apt to live. Those with a 
bad match were presumably ruthlessly weeded 
out. The unacceptability of this approach was 
particularly well demonstrated by the very poor 
long-term survival when randomly selected 
non-related donors were used. During that era 
there was virtually no available information on 
the location, nature and number of human 
histocompatibility antigens. 
Subsequently, hope that practical tissue typ- 
ing schemes are not far off has stemmed from 
investigations of isoimmune antisera obtained 
from patients who have accidentally or deliber- 
ately been sensitized to white cell antigens. The 
agglutination,or cytolysis of test cells by such 
antisera implies the presence of the same or a 
similar antigen as that which originally sensi- 
tized the serum donor; failure of such a reac- 
tion implies the absence of the antigen. Using 
these sera the white cell antigenic differences 
and similarities between recipients and pros- 
pective donors can be compared. 
Initially, it was not clear if those antigenic 
systems being studied had any relation to histo- 
compatibility. Recently, however, evidence has 
been forthcoming that this may be the case. 
The most convincing studies have come from 
Terasaki of Los Angeles who prospectively 
typed a group of patients treated in Denver 
from 13 to 20 months ago. Thirteen of these 
patients received kidneys from non-related 
sources, the actual donor being selected from a 
large pool on the basis of the best possible 
antigen match with the recipient; because of 
the large donor panel, a relatively high degree 
of selectivity was possible. The other 13 were 
provided with kidneys from familial donors. 
The limited number of family members did not 
allow a high degree of selectivity in this latter 
group, and in fact the quality of donor- 
recipient antigen match was scarcely better 
than would have b'een achieved through chance 
intrafamilial pairing. 
The outcome in this small group of cases is 
depicted in Figure 3. During the time of avail- 
able follow-up, the results are exactly the same 
in both related and non-related cases. Even 
though the present techniques of antigenic an- 
alysis are cumbersome and imprecise, these 
preliminary results are distinctly encouraging. 
If and when such techniques can bc applied to 
selection of cadaveric kidneys, many of the 
ethical and social problems imposed by em- 
ployment of living donors will be subject to 
elimination. 
WHY IS SUCCESSFUL TRANSPLANTATION 
POSSIBLE? 
The most important drug which has changed 
the outlook after renal homotransplantation has 
been 6-mercaptopurine, an agent demonstrated 
by Schwartz and Dameshek to blunt the im- 
munologic response in animals exposed to 
various foreign proteins. Subsequently an 
imidazole derivative of 6-mercaptopurine, 
termed azathioprine, was developed by Dr. 
George H. Hitchings of the Burroughs Wel- 
200 MEDICAL TIMES 
come Co. and demonstrated by Calne, Zuko- 
ski and others to  markedly potentiate homo- 
graft survival. Although both 6-mercapto- 
purine and azathioprine are known to inhibit 
DNA synthesis, the way in which they prevent 
or attenuate rejection is incompletely under- 
stood. In overdosage, both cause bone mar- 
row suppression but this toxic effect is not 
necessary for therapeutic efficacy. 
With the immunosuppressive protocol now 
widely employed, azathioprine forms the cor- 
nerstone of therapy. Administration is started 
in advance of operation and continued indefi- 
nitely thereafter. In most cases, however, 
azathioprine therapy alone is insufficient to 
prevent homograft repudiation. The employ- 
ment of prednisone as a second drug is almost 
always necessary. It  can either be used prophy- 
lactically from the time of operation or can be 
instituted at the time of a rejection crisis. Other 
adjuvant measures such as intravenous acti- 
nomycin C or local homograft irradiation may 
be useful either prophylactically or during a re- 
jection episode but their effect is much more 
limited. 
One way in which azathioprine and predni- 
sone can be employed is demonstrated in 
Figure 4. The patient received azathioprine 
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FIGURE 3 Results o f  renal transplantation in a more 
recent series of patients, whose donors were selected by 
Terasaki's antigen matching method. Note that survival 
after 13 months was exactly the same in both the related 
and non-related cases; all of these patients are now from 
13 t o  20 months postoperative. Compare these results 
with those shown in Figure 2. 
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FIGURE 4 Classical reiection crisis in patient treated 
with drugs alone. Deterioration of renal function began 
19 days after transplantation. Al l  stigmata o f  rejection 
are present except for acute hypertension and weight 
gain, which were successfully prevented by medical treat- 
ment. Note the complete reversal of these adverse events 
after the institution of steroid therapy. Six months later 
prednisone was discontinued. The patient who was oper- 
ated upon in Apr i l  of 1963 has completely normal renal 
function more than three years later. A renal biopsy 
after two years was normal both by light and electron 
microscopy. Acti-C-Actinomycin C; LN-left nephrec- 
tomy a t  time o f  transplantation; RN-right nephrectomy. 
lmuran is synonymous with azathioprine. (By permission 
of Surg., Gynec. & Obst. 117:385, 1963) 
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both before and after the time of his trans- 
plantation. There was an immediate postoper- 
ative diuresis with complete relief of azotemia. 
The benefit was, however, short lived. Nine- 
teen days later the BUN began to rise second- 
arily. The creatinine clearance dropped sharp- 
ly. He developed fever and there was an in- 
crease in proteinuria. The addition of large 
doses of prednisone caused a prompt reversal 
of all of these adverse events. There was a 
sharp diuresis, restoration of creatinine clear- 
ance, and disappearance of the urine protein. 
The acute fever was relieved within hours after 
the first steroid dose. 
The course of this patient demonstrates two 
important principles which have emerged far 
more clearly from clinical studies than from 
observations in animal experiments. The first 
was that rejection is a reversible process, con- 
trary to the deeply entrenched and pessimistic 
historical view. The second principle concerns 
the apparent change in host-graft reactivity that 
evidently occurs rather early after successful 
renal transplantation. The patient whose course 
is depicted in Figure 4 illustrates this alteration. 
In this case, it was initially impossible to main- 
tain good homograft function by means of 
azathioprine therapy alone. Within 6 months, 
however, at which time prednisone was 
stopped, his course was perfectly stable while 
being treated solely with azathioprine. He is 
now more than 3 years postoperative and has 
never had further difficulty. 
The reversibility of rejection and the often 
observed diminishing requirement for im- 
munosuppression are the most important prac- 
tical events which make it possible to achieve 
chronic survival. In view of these observations, 
it is reasonable to wonder if chronically surviv- 
ing patients require any immunosuppression at 
all for maintenance of homograft function. In 
dogs this possibility has been evaluated in a 
number of animals by stopping therapy 4 
months to 2 years after replacement of either 
kidney or liver homografts. Approximately 1 
out of every 3 such grafts will continue to func- 
tion without any evidence of further injury. 
Five animals have been followed in our lab- 
oratory from 2 to more than 3 years under 
these circumstances. Unfortunately, it has been 
impossible to predict which animals will be- 
have in this way and which will reject their 
homografts. It  is not, therefore, safe to stop 
therapy in comparable patients. 
The explanation for the change in host-graft 
reactivity is obscure. It is not known if there is 
an alteration in the host, if alternatively there is 
some change in the antigenic constitution of 
the graft, or if both factors contribute. The 
hypo.thesis that an enhancement phenomenon 
was responsible was weakened in the past by 
the fact that circulating antigraft antibodies 
which are necessary for tumor enhancement 
could not be consistently demonstrated in either 
dogs or man after renal homotransplantation. 
The possibility that enhancement may be a fac- 
tor in the development of "host-graft non-re- 
activity" has recently been strengthened by 
Iwasaki's demonstration in our laboratories of 
the presence of highly specific antibodies in the 
sera of almost all patients after clinical renal 
transplantation. 
Were it not for the change in host-graft 
reactivity described above, it would be ex- 
pected that chronic renal function could be ob- 
tained only at the expense of nearly complete 
immunologic crippling of the recipient. In 
many cases this has not been necessary par- 
ticularly when survival beyond the first few 
months was achieved. Nevertheless, some loss 
of reactivity to foreign antigens is inevitable in 
every case. Furthermore, the degree of this 
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FIGURE 5 Typical unsuccessfully treated case. The 
donor and recipient were brothers, both of A blood type. 
A violent reiection crisis followed good early function, 
and anuria developed which lasted two weeks. Although 
the reiection was reversed and a secondary diuresis began, 
the patient died from drug toxicity, leukopenia, and septi- 
cemia. Ac t i  C-Each arrow is 200 ug intravenous actino- 
mycin C. (By permission of Surgery 56:296. 1964) 
loss during the early convalescence when maxi- first few post-transplant weeks or months. Al- 
mum immunosuppression is employed is so most invariably these unsuccessfully treated 
great that the margin of safety at this time is cases follow a typical pattern (Figure 5). After 
extremely slim. It is not surprising therefore transplantation good homograft function is ob- 
that most of the deaths occur early, with'n the served. With a subsequent rejection crisis and 
204 MEDICAL TIMES 
with intensification of immunosuppressive ther- 
apy the rejection can be controlled but often 
at the price of fatal sepsis. The patient illus- 
trated in Figure 5 had a severe but reversible 
rejection. As renal function was improving, he 
died of a systemic fungal and bacterial infec- 
tion. 
The use of azathioprine to prevent rejection 
of kidney homografts presents special problems 
of toxicity because of the fact that this drug has 
an important renal pathway of excretion, nor- 
mally accounting for 25-50% of the ingested 
dose. During the early postoperative period 
when renal function is very often unstable, the 
amount of azathioprine eliminated through the 
urine may vary from day to day or from hour 
to hour. As a consequence, dose control is ex- 
ceedingly difficult. The poor results obtained 
several years ago with cadaveric homotrans- 
plantation may have been partly due to lack of 
appreciation of this fact. Such patients whose 
homografts often must pass through a period 
of acute tubular necrosis before urine excre- 
tion commences cannot be treated early with as 
large a quantity of azathioprine as patients who 
receive well-functioning kidneys from living 
donors. 
The sepsis which results from miscalculation 
of dosage has been the subject of considerable 
study. The majority of infections are caused 
by coliimon pyogenic organisms but there is 
also a high incidence of unusual infections with 
fun$. protozoa (such as Pneumocystis carinii). 
and viruses (such a.s those of hepatitis, cytome- 
galic inclusion disease, or herpes zoster). 
Although the acute threat of sepsis dimin- 
ishes after the first few months, a continued 
morbidity due to the immunosuppressive 
agents has been observed. Chronic liver disease 
has been a problem in many patients. In some, 
this apparently started as a viral hepatitis; one 
such patient died 157 days after operation from 
acute yellow atrophy. In others jaundice has 
appeared and waxed and waned for as long as 
1 year. In still others, hypoproteinemia and 
decreased bromsulphalein (BSP) excretion have 
been observed without evident antecedent acute 
liver disease. In many cases the cause for these 
hepatic complications has not been clear. In 
dogs, azathioprine is highly hepatotoxic, but 
the evidence that the human liver is similarly 
affected is equivocal. Steroids can cause fatty 
metamorphosis or even cirrhosis when admin- 
istered to experimental animals for protracted 
periods. In any event, the patient with renal 
homotransplantation must have hepatic func- 
tion followed with care. 
In addition, other late problems have been 
observed with range from nuisance factors to 
life-threatening complications. The most con- 
sistent complaints are from patients who re- 
quire long-term steroid therapy. The cosmetic 
deformity when high doses must be continued 
chronically is the cause of much concern par- 
ticularly to female patients. Infants and chil- 
dren whose continued renal function is steroid 
dependent do not grow. Parhologic fractures of 
the femoral neck or vertebrae have been seen 
in 4 patients apparently secondary to steroid- 
induced osteoporosis. 
Mechanical urological problen~s must be 
looked for at routine intervals. Late strictures 
either at the ureteral anastomosis to the re- 
cipient ureter or the bladder have been de- 
tected in 4 patients and in anolher one a stric- 
ture developcd apparently on the basis of scar- 
ring at the site of a previous ureteral rejection. 
LATE HOMOGRAFT UNCTION 
The most serious late morbidity, however, is 
due to continued immunologic activity against 
the graft. More than a dozen patients amongst 
our group of chronic survivors have had de- 
terioration of homograft function from 4 
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months to more than 1% years postopera- 
tively. When this complication has occurred it 
had almost invariably followed reduction' of 
the steroid dose. The development of late re- 
jection under these circumstances constitutes 
a very long-term or even permanent commit- 
ment of the patient to steroid therapy. In many 
cases the development of a late rejection epi- 
sode is not dissimilar to that classically ob- 
served in the first few weeks. Fever, abrupt 
oliguria, and rapidly developing azotemia may 
be seen. This kind of late rejection can usually 
be controlled, the most important step being an 
adjustment of the steroid dose. 
A more insidious form of late rejection may 
cause a very gradual loss of renal function over 
a period of many months. This slow functional 
deterioration is not strikingly influenced by 
intensification of immunosuppression. 
Chronic homograft function in the recipients 
of kidneys from blood relatives has been much 
more stable than in non-related cases. In the 
former group, studies of creatinine, inulin, and 
PAH clearances have shown a drop in only a 
few cases between the first and second years. 
The recipients of randomly selected non-re- 
lated kidneys in our original series have, in 
contrast, almost invariably shown a gradual 
decline in function not only in the first, but 
also in the second and third postoperative 
years. Whether function will be more stable in 
the more recent series of non-related cases in 
which donor-recipient antigen matching was 
performed can be answered only by longer 
follow-up. 
LATE PATHOLOGIC CHANGES 
Homograft tissue from 36 of the Denver 
cases has been obtained from 1 to more than 2 
years after operation, either as the result of 
open biopsy or in 3 cases from autopsy tissue. 
The resulting pathologic studies performed by 
Dr. K. A. Porter of St. Mary's Hospital and 
Medical School, London, have clarified many 
of the pathologic features of the chronically 
tolerated and functional homograft. At 2 years 
approximately 20% of these kidneys were 
either completely normal or had relatively in- 
significant changes. The others had an assort- 
ment of abnormalities which were often not 
associated with serious impairment of renal 
function. 
There were vascular lesions which had many 
forms; fibrous intimal thickening of interlobu- 
lar arteries often with rupture or duplication 
of the internal elastic lamina, deposition of a 
hyaline-like substance in the subintimal layer 
of afferent arterioles, and deposition of the 
PAS-positive hyaline material in the glomer- 
ular capillaries. The homografts with vascular 
lesions often had other secondary morphologic 
changes; fibrosis of the glomerular tuft, peri- 
glomerular fibrosis, interstitial fibrosis, or 
tubular atrophy. 
In addition, the majority of the homografts 
contained focal accumulations of mononuclear 
cells. Ten to 40% of these cells consisted of 
the pyronine positive variety which are tradi- 
tionally found in acutely rejecting homografts. 
In the chronically functioning homografts, they 
seemed to be reasonably well tolerated. 
The answer to this question has not been 
made easier by the improved results after renal 
homotransplantation during the past few years 
since this type of therapy is still a hazardous 
undertaking. Furthermore, the life expectancy 
of those patients still living by virtue of their 
chronically functioning homografts is not 
known. On the other hand, more than half of 
the patient treated in the era when pessimism 
was most widespread are still alive for more 
than 2 to almost 4 years later. 
MEDICAL TIMES 
Perhaps the best approach would be to pre- 
sent the actual statistics, initially making no 
effort to editorialize one way or the other. It  
is important also to paint an accurate picture 
of the financial sacrifice and the morbidity 
which may have to be borne by the patient and 
his family. If a truly honest presentation is 
made, the uremic individual and his family will 
often come to a firm decision without further 
guidance. Very often this decision will be neg- 
ative and surprisingly frequently it will be the 
patient himself who declines further consider- 
ation of therapy either with renal transplanta- 
tion or with chronic renal dialysis. 
It is only when such an objective approach 
is not taken that the physician-patient relation- 
ship is threatened. Under these circumstances, 
a bereaved family may later come to feel that 
a lost one has been cheated of a form of avail- 
able therapy, or alternatively in the event of a 
failed transplant, they may conclude that the 
potential of the method had been oversold. 
THE FUTURE OF RENAL TRANSPLANTATION 
The methods of organ transplantation em- 
ployed now will surely seem ridiculously im- 
precise to future generations of physicians. 
What has been achieved to date establishes 
unequivocally that renal homotransplantation 
can materially prolong useful life for many pa- 
tients. However, the best results today are 
dependent upon a procedure which will be un- 
acceptable in the long run, namely the use of 
living donors. It is mandatory that techniques 
be perfected to the point that cadaveric organs 
can be used with consistent success. Salvage 
could then be offered to the sick patient with- 
out the necessity of subjecting well motivated 
healthy individuals to medical and surgical 
procedures. 
In order to make this possible, developments 
are necessary in 3 general areas. First, the typ- 
ing techniques described earlier, must be re- 
fined and applied to the matching of cadaveric 
organs against potential recipients. Secondly, 
new, more specific, and safer immunosuppres- 
sive regimens must be evolved. The most 
promising research in immunosuppression in 
the recent past has been with heterologous anti- 
lymphocyte sera. This material is prepared by 
immunizing animals against the lymphoid tis- 
sues of another species. The serum of the im- 
munized animal can then be collected, purified, 
and injected back into members of the donor 
series w'th resulting lymphopenia. The anti- 
lymphocyte antibody is in the gamma globulin, 
the administration of which has been found 
experimentally to be well tolerated. Its use has 
permitted the long term survival of homografts 
in rats, mice, guinea pigs, and dogs. 
Finally, much more effort will be required 
for effective utilization of cadaveric organs. 
The present methods of tissue preservation are 
crude and effective only for short intervals. Im- 
provements in organ preservation could permit 
the establishment of banks containing organs 
which could be studied for histocompatibility 
characteristics and used electively as needed. 
To make this possible, a program of public 
education will be required of the same kind as 
that which has been so successful for the estab- 
lishment of eye banks. 
Since the autumn of 1965,7 cadaveric trans- 
plantations have been performed at the Uni- 
versity of Colorado Medical Center, with at- 
tention to some but not all of the above details; 
the general technique of immunosuppression 
was not altered from that used in the past for 
living donor cases. Five of these 7 patients are 
still alive from 3 to 8 months postoperatively. 
These results contrast sharply with those 
obtained with 3 comparable cases in 1963 
in which all 3 recipients died within 2 
months. 
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Summary 
Progre.rs in lzotnotransplantation of the kid- 
ney has been reviewed. This form of therapy 
for the patient with terminal uremia has re- 
sulted in a 2-year survival of more than 50% 
at the Univer~ity of Colorado Medical Center, 
excludirzg from consideration identical twin 
cases. The best results were with the use o f  
kidneys obtained from familial donors; when 
this has been possible the 2-year survival is al- 
most %. With randomly selected non-related 
living donors the 2-year survival was only 
22%.  
Although these results indicate the great po- 
tential value o f  organ transplantation, the tech- 
niques being employed today are imperfect. 
The need for progress with better immuno- 
suppression, better histocompatibility analysi.~, 
and better organ preservation are outlined. 
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